Robert Hart, Forbes Staff

Author's posts

Nestlé Is Developing Products To Accompany Weight-Loss Drugs Like Ozempic— Amid Fears They’ll Eat Into Food Sales

Nestlé’s chief executive said the appetite-killing drugs hadn’t cut into food sales yet—but created an opportunity for supplements and products to help people keep weight off.

Kitten With ‘New’ Rabies Strain Triggers Health Push In Nebraska To Stop Deadly Virus Gaining A Foothold

Officials said the variant, normally found in raccoons, is “something that can snowball very quickly” and could put many people in danger.

Vaccine Stocks—Including Pfizer, Moderna, BioNTech And Novavax—Slide Amid Plummeting Demand

Pfizer slashed its revenue forecasts on Friday amid falling demand for its Covid vaccine and antiviral drug Paxlovid.

GSK Settles Zantac Cases After Claims Popular Heartburn Drug Causes Cancer

The pharma giant settled four cases in California for an undisclosed amount to avoid the “distraction” of a trial.

Idaho Abortion Ban Partly On Hold Again As Full Appeals Court Weighs In On Biden’s Challenge

The full Ninth Circuit voted to hear the Biden Administration’s challenge to Idaho’s abortion ban during medical emergencies, voiding an earlier decision from three Trump-appointed judges on the court.

Painful Dengue May ‘Take Off’ In United States—What To Know About The ‘Breakbone Fever’ Virus

Four states—Florida, Hawaii, Texas and Arizona—have already documented locally acquired cases of dengue, which is also known as “breakbone fever” on account of the severe pain it causes.

Elon Musk Says Neuralink Could Slash Risk From AI As Firm Prepares For First Human Trials

In the shorter term, Musk said Neuralink could help restore body movement and when combined with Tesla’s robotics could make the “Luke Skywalker solution” a reality.

Ultra-Processed Food—Especially Artificial Sweeteners—Linked To Depression, Study Finds

People with diets high in ultra-processed foods—products made with industrial ingredients and often loaded with chemical additives—had around a 50% higher risk of depression, researchers found.

FDA Rejects Nasal Spray For Severe Allergic Reactions—Delaying First Needle-Free EpiPen Alternative

ARS Pharmaceuticals chief executive Richard Lowenthal said the company is “very surprised” and “deeply disappointed” by the FDA’s decision.

What To Know About The Deadly Nipah Virus As India Races To Contain Outbreak

Feared as a potential cause of another pandemic, Nipah has no treatments or vaccines, and the virus kills as many as three out of every four people it infects.